Adage Capital Partners
IMGN

Adage Capital Partners’s Immunogen Inc IMGN Stock Holding History

Adage Capital Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-971,928
Closed -$28.8M – 974
2023
Q4 		$28.8M Buy
971,928
+771,928
+386% +$15.4M 0.06% 331
2023
Q3 		$3.17M Sell
200,000
-450,000
-69% -$7.48M 0.01% 711
2023
Q2 		$12.3M Sell
650,000
-16,982,815
-96% -$201M 0.03% 529
2023
Q1 		$67.7M Buy
17,632,815
+6,513,815
+59% +$27.8M 0.15% 163
2022
Q4 		$55.2M Buy
11,119,000
+3,219,000
+41% +$17.5M 0.13% 189
2022
Q3 		$37.8M Sell
7,900,000
-3,686,193
-32% -$19.4M 0.09% 232
2022
Q2 		$52.1M Hold
11,586,193
– – 0.12% 178
2022
Q1 		$55.1M Buy
11,586,193
+1,300,000
+13% +$7.2M 0.1% 190
2021
Q4 		$76.3M Buy
10,286,193
+2,536,193
+33% +$15.8M 0.14% 157
2021
Q3 		$43.9M Buy
7,750,000
+750,000
+11% +$4.33M 0.09% 237
2021
Q2 		$46.1M Buy
7,000,000
+2,500,000
+56% +$17.4M 0.09% 226
2021
Q1 		$36.5M Buy
4,500,000
+2,025,000
+82% +$16.5M 0.07% 287
2020
Q4 		$16M Buy
+2,475,000
New +$14.4M 0.03% 477

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Adage Capital Partners's IMGN Position: Q1 2024 in Review

Adage Capital Partners sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 971,928 shares — an estimated $28.8M sold.

Adage Capital Partners first reported a position in IMGN in Q4 2020 and held it in 13 quarters. The position peaked at $76.3M in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Adage Capital Partners reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Adage Capital Partners sold 971,928 Immunogen Inc shares in Q1 2024, an estimated $28.8M.
  • Adage Capital Partners first reported a position in Immunogen Inc in Q4 2020 and held it in 13 quarters.
  • Adage Capital Partners's Immunogen Inc position peaked at $76.3M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.